<DOC>
	<DOCNO>NCT00149188</DOCNO>
	<brief_summary>The purpose study allow patient acromegaly , partner , learn successfully inject Somatuline Autogel home . Ability perform unsupervised injection whilst maintain adequate disease control assess .</brief_summary>
	<brief_title>Somatuline Autogel : Acromegaly Self/Partner Injection Study</brief_title>
	<detailed_description />
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Lanreotide</mesh_term>
	<mesh_term>Angiopeptin</mesh_term>
	<criteria>The patient must clinical diagnosis acromegaly The patient must test show GH level less equal 10 micrograms/L within 28 day prior baseline visit The patient must currently treat Somatuline Autogel stable current dose least 6 month immediately prior screen The patient must able store study medication refrigerator home The patient pituitary surgery ( adenomectomy ) within 6 month prior screen The patient receive pituitary radiotherapy within one year prior screen The patient likely require pituitary surgery ( adenomectomy ) receive radiotherapy study period The patient currently receive GH antagonist somatostatin analogue Somatuline Autogel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Growth Hormone</keyword>
</DOC>